Cardiac Imaging

While cardiac ultrasound is the widely used imaging modality for heart assessments, computed tomography (CT), magnetic resonance imaging (MRI) and nuclear imaging are also used and are often complimentary, each offering specific details about the heart other modalities cannot. For this reason the clinical question being asked often determines the imaging test that will be used.

AI-based coronary plaque evaluations highlight elevated heart risks in women
“This is the perfect technique to identify high-risk patients who would benefit from intensive therapies,” imaging specialist Gudrun Feuchtner, MD, told Cardiovascular Business.
FDA warns that certain coronary imaging catheters are being removed from market over safety concerns
A catheter sheath detached during use and was left in the patient’s body. It was successfully removed, but the FDA said it is now evaluating the potential risk to others going forward. There is no official recall at this time.
Family of heart patient who died awarded $45M after suing health system for negligence
The 55-year-old patient woke up experiencing chest pain one morning and an ambulance was called. He was dead just a few hours later. His family's lawsuit argued that delays in care, communication errors and other issues were directly responsible for his death.
Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women
Coronary artery disease is both underdiagnosed and undertreated in women, and they often receive less guideline-recommended care than men. Why do these disparities persist? And what can today’s healthcare providers do to bring about change?
FDA clears catheter-based 4D visualization platform for complex heart procedures
The new technology from LUMA Vision allows operators to deliver 2D and 4D ultrasound images in real time. The advanced catheter was built with maneuverability and increased visibility in mind.

Regulatory Roundup: Updates on Medtronic and LivaNova recalls, FDA-cleared AI models, a new heart valve and more

Read our recap of some of the biggest FDA-related stories that impacted cardiology in the last month.

A study that analyzed patient outcomes in coronary artery bypass grafting (CABG) in veterans showed outcomes for on-pump and off-pump procedures over 10 years to be similar. Photo by Jim Lennon

Radial artery grafts vs. saphenous vein grafts for CABG: Does one outperform the other?

The new study, published in Circulation, represents a collaboration between specialists from a variety of facilities, including Cleveland Clinic and the University of Arizona.

Canon to open new subsidiary, Canon Healthcare USA, in Cleveland

“The U.S. market is more and more important for our business,” the company's president and CEO said during a press conference at RSNA 2022.

The power of AI: Advanced algorithm IDs heart issues using Apple Watch data

A team of Mayo Clinic specialists led the analysis, sharing their findings in Nature Medicine.

Early catheter ablation superior to medication when treating ventricular tachycardia storm

VT storm is associated with a heightened risk of death or significant complications. Early catheter ablation, it seems, is the most effective treatment option for this potentially fatal condition.

Interview with the late-breaking BEST-CLI trial principal investigators Alik Farber from Boston Medical Center, Matthew Menard from Brigham and Women's Hospital, and Ken Rosenfield at Mass General Hospital, at the 2022 American Heart Association (AHA) meeting. The trial looked at endovascular versus bypass surgery in patients with critical limb ischemia (CLI) to see which is better. #AHA22

VIDEO: Surgery vs. endovascular intervention for critical limb ischemia in the BEST-CLI trial

Watch our exclusive interview, recorded live at the AHA Scientific Sessions 2022 conference, with three investigators from the BEST-CLI trial.

Jason Andrade, MD, FRCPC, FHRS, director of electrophysiology, Vancouver General Hospital, clinical associate professor, University of British Columbia, and principal investigator for the PROGRESSIVE AF trial, explains how cryoablation can be used as a front-line treatment for atrial fibrillation (AFib). He presented this late-breaking trial at the American Heart Association (AHA) 2022 meeting, which showed the therapy can be used instead of trying drug therapy first. #AHA22 #EPeeps

VIDEO: Cryoablation can be used as frontline therapy before drugs: PROGRESSIVE AF trial

Jason Andrade, MD, director of electrophysiology, Vancouver General Hospital, and principal investigator of the PROGRESSIVE AF trial, explains how cryoablation can be used as a frontline treatment for atrial fibrillation (AFib) before drugs in this AHA late-breaker.

Brian Lindman, MD, MSCI, medical director of the Structural Heart and Valve Center and an associate professor of medicine, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program. It was announced at the AHA 2022 meeting and is designed to help screen with echo to find more AS patients.

VIDEO: AHA says aortic stenosis is undertreated and underdiagnosed

Brian Lindman, MD, medical director of the Structural Heart and Valve Center, Vanderbilt University Medical Center, explains the new American Heart Association (AHA) Target Aortic Stenosis (AS) program to screen with echo to find more AS patients.

Cardiac Imaging

AI-based coronary plaque evaluations highlight elevated heart risks in women

FDA warns that certain coronary imaging catheters are being removed from market over safety concerns

Family of heart patient who died awarded $45M after suing health system for negligence

Cardiology, radiology professionals unite to explore the challenges of diagnosing CAD in women

FDA clears catheter-based 4D visualization platform for complex heart procedures